CircRNA SCAR Improves High-Glucose-Induced Mitochondrial Dysfunction and Permeability Damage in Retinal Microvascular Endothelial Cells

Abstract

This study was designed to assess the role and mechanism of circRNA SCAR in human retinal microvascular endothelial cells (hRMVECs) treated with high glucose. Quantitative real-time polymerase chain reaction (qRT-PCR) and cell counting kit 8 (CCK-8) were used to detect the effects of different concentrations of glucose on circRNA SCAR expression and cell proliferation in hRMVECs. Cell viability, levels of oxygen species (ROS), malondialdehyde (MDA) and adenosine triphosphate (ATP), as well as activities of antioxidant enzymes superoxide dismutase (SOD) and catalase (CAT) in the transfected hRMVECs in each group were detected using CCK-8 and their corresponding detection kits. Changes in mtDNA copy number in high-glucose-induced hRMVECs were observed by qRT-PCR. Additionally, western blot was applied to detect effect of overexpressing circRNA SCAR on the expression levels of mitochondrial function-related proteins (Drp1 and Fis1) and cell permeability-related proteins (claudin-5, occludin and ZO-1) in hRMVECs under high-glucose concentration. According to experimental results, high glucose significantly downregulated circRNA SCAR expression and inhibited cell proliferation in hRMVECs. Instead, overexpression of this circRNA SCAR promoted cell proliferation, reduced levels of ROS, MDA and ATP, and increased SOD and CAT activities in hRMVECs under high-glucose concentration. Also, circRNA SCAR overexpression reversed the high-glucose-induced decrease in mtDNA copy number as well as, high-glucose-induced upregulation of Drp1 and Fis1 protein expression and downregulation of claudin-5, occludin and ZO-1 protein expression in hRMVECs. In summary, circRNA SCAR promotes the proliferation of hRMVECs under high-glucose concentration, alleviates oxidative stress induced by high glucose, and improves mitochondrial function and permeability damage.

Key words

retinal microvascular endothelial cells - high glucose - mitochondrial dysfunction - circRNA SCAR

• References

• 1 Guariguata L, Whiting DR, Hambleton I. et al. Global estimates of diabetes prevalence for 2013 and projections for 2035. Diabetes Res Clin Pract 2014; 103: 137-149
• 2 Jourdan T, Szanda G, Cinar R. et al. Developmental role of macrophage cannabinoid-1 receptor signaling in type 2 diabetes. Diabetes 2017; 66: 994-1007
• 3 Leasher JL, Bourne RR, Flaxman SR. et al. Global estimates on the number of people blind or visually impaired by diabetic retinopathy: a meta-analysis from 1990 to 2010. Diabetes Care 2016; 39: 1643-1649
• 4 Wong TY, Cheung CM, Larsen M. et al. Diabetic retinopathy. Nat Rev Dis Primers 2016; 2: 16012
• 5 Semba RD, Huang H, Lutty GA. et al. The role of O-GlcNAc signaling in the pathogenesis of diabetic retinopathy. Proteomics Clin Appl 2014; 8: 218-231
• 6 Zhang MY, Zhu L, Zheng X. et al. TGR5 Activation ameliorates mitochondrial homeostasis via regulating the PKCdelta/Drp1-HK2 signaling in diabetic retinopathy. Front Cell Dev Biol 2021; 9: 759421
• 7 Miller DJ, Cascio MA, Rosca MG. Diabetic retinopathy: the role of mitochondria in the neural retina and microvascular disease. Antioxidants (Basel) 2020; 9: 905
• 8 Ma Z, Wirstrom T, Borg LA. et al. Diabetes reduces beta-cell mitochondria and induces distinct morphological abnormalities, which are reproducible by high glucose in vitro with attendant dysfunction. Islets 2012; 4: 233-242
• 9 Li X, Zhang M, Zhou H. The morphological features and mitochondrial oxidative stress mechanism of the retinal neurons apoptosis in early diabetic rats. J Diabetes Res 2014; 2014: 678123
• 10 Rudraraju M, Narayanan SP, Somanath PR. Regulation of blood-retinal barrier cell-junctions in diabetic retinopathy. Pharmacol Res 2020; 161: 105115
• 11 Felinski EA, Cox AE, Phillips BE, Antonetti DA. Glucocorticoids induce transactivation of tight junction genes occludin and claudin-5 in retinal endothelial cells via a novel cis-element. Exp Eye Res 2008; 86: 867-878
• 12 Jo DH, Yun JH, Cho CS. et al. Interaction between microglia and retinal pigment epithelial cells determines the integrity of outer blood-retinal barrier in diabetic retinopathy. Glia 2019; 67: 321-331
• 13 Leal EC, Martins J, Voabil P. et al. Calcium dobesilate inhibits the alterations in tight junction proteins and leukocyte adhesion to retinal endothelial cells induced by diabetes. Diabetes 2010; 59: 2637-2645
• 14 Tang L, Zhang C, Yang Q. et al. Melatonin maintains inner blood-retinal barrier via inhibition of p38/TXNIP/NF-kappaB pathway in diabetic retinopathy. J Cell Physiol 2021; 236: 5848-5864
• 15 Nicolet BP, Engels S, Aglialoro F. et al. Circular RNA expression in human hematopoietic cells is widespread and cell-type specific. Nucleic Acids Res 2018; 46: 8168-8180
• 16 He M, Wang W, Yu H. et al. Comparison of expression profiling of circular RNAs in vitreous humour between diabetic retinopathy and non-diabetes mellitus patients. Acta Diabetol 2020; 57: 479-489
• 17 Zhou HR, Kuang HY. Circular RNAs: Novel target of diabetic retinopathy. Rev Endocr Metab Disord 2021; 22: 205-216
• 18 Chang X, Zhu G, Cai Z. et al. miRNA, lncRNA and circRNA: Targeted molecules full of therapeutic prospects in the development of diabetic retinopathy. Front Endocrinol (Lausanne) 2021; 12: 771552
• 19 Guo N, Liu XF, Pant OP. et al. Circular RNAs: novel promising biomarkers in ocular diseases. Int J Med Sci 2019; 16: 513-518
• 20 Liu C, Yao MD, Li CP. et al. Silencing of circular RNA-ZNF609 ameliorates vascular endothelial dysfunction. Theranostics 2017; 7: 2863-2877
• 21 Zeng Q, Liu J. Silencing circ_0001879 inhibits the proliferation and migration of human retinal microvascular endothelial cells under high-glucose concentration via modulating miR-30-3p. Gene 2020; 760: 144992
• 22 Liu G, Zhou S, Li X. et al. Inhibition of hsa_circ_0002570 suppresses high-glucose-induced angiogenesis and inflammation in retinal microvascular endothelial cells through miR-1243/angiomotin axis. Cell Stress Chaperones 2020; 25: 767-777
• 23 Zhao Q, Liu J, Deng H. et al. Targeting mitochondria-located circRNA SCAR alleviates NASH via reducing mROS output. Cell 2020; 183: e22
• 24 Pandey D, Yevale A, Naha R. et al. Mitochondrial DNA copy number variation – a potential biomarker for early onset preeclampsia. Pregnancy Hypertens 2021; 23: 1-4
• 25 Adzraku SY, Wang G, Cao C. et al. Robo4 inhibits gamma radiation-induced permeability of a murine microvascular endothelial cell by regulating the junctions. Cell Mol Biol Lett 2023; 28: 2
• 26 Feng Y, Wang R, Xu J. et al. Hydrogen-rich saline prevents early neurovascular dysfunction resulting from inhibition of oxidative stress in STZ-diabetic rats. Curr Eye Res 2013; 38: 396-404
• 27 Wu MY, Yiang GT, Lai TT. et al. The oxidative stress and mitochondrial dysfunction during the pathogenesis of diabetic retinopathy. Oxid Med Cell Longev 2018; 3420187
• 28 Naruse R, Suetsugu M, Terasawa T. et al. Oxidative stress and antioxidative potency are closely associated with diabetic retinopathy and nephropathy in patients with type 2 diabetes. Saudi Med J 2013; 34: 135-141
• 29 Lu L, Lu Q, Chen W. et al. Vitamin D(3) protects against diabetic retinopathy by inhibiting high-glucose-induced activation of the ROS/TXNIP/NLRP3 inflammasome pathway. J Diabetes Res 2018; 8193523
• 30 Fan Y, Qiao Y, Huang J. et al. Protective effects of panax notoginseng saponins against high glucose-induced oxidative injury in rat retinal capillary endothelial cells. Evid Based Complement Alternat Med 2016; 5326382
• 31 Jeong HY, Kang JM, Jun HH. et al. Chloroquine and amodiaquine enhance AMPK phosphorylation and improve mitochondrial fragmentation in diabetic tubulopathy. Sci Rep 2018; 8: 8774
• 32 Chang JY, Yu F, Shi L. et al. Melatonin affects mitochondrial fission/fusion dynamics in the diabetic retina. J Diabetes Res 2019; 8463125
• 33 Kim D, Sankaramoorthy A, Roy S. Downregulation of Drp1 and Fis1 inhibits mitochondrial fission and prevents high glucose-induced apoptosis in retinal endothelial cells. Cells 2020; 9: 1662
• 34 Stitt AW, Curtis TM, Chen M. et al. The progress in understanding and treatment of diabetic retinopathy. Prog Retin Eye Res 2016; 51: 156-186